Clonorchiasis
3
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
3
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
1100%
+ 2 programs with unclassified modality
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Autonomous TherapeuticsMD - Rockville
3 programs3
AlbendazolePhase 4Small Molecule1 trial
PraziquantelPhase 4
TribendimidinePhase 4
Active Trials
Trial Timeline
Clinical trial activity over time
2025
2026
Autonomous TherapeuticsAlbendazole
Clinical Trials (1)
Total enrollment: 318 patients across 1 trials
Treatment of Clonorchiasis in Guangxi With Albendazole, Tribendimidine, and Praziquantel
Start: Jul 2025Est. completion: Dec 2026318 patients
Phase 4Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 318 patients
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.